Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.9%

5 terminated/withdrawn out of 36 trials

Success Rate

86.1%

-0.4% vs industry average

Late-Stage Pipeline

14%

5 trials in Phase 3/4

Results Transparency

6%

2 of 31 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1
30(83.3%)
Phase 3
5(13.9%)
Phase 2
1(2.8%)
36Total
Phase 1(30)
Phase 3(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials
NCT03297502Phase 3Completed

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Role: lead

NCT00652704Phase 1Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

Role: lead

NCT01380496Phase 1Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

Role: lead

NCT00652873Phase 1Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

Role: lead

NCT00653003Phase 1Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

Role: lead

NCT00652600Phase 1Completed

Bioavailability Study of Propranolol Under Fed Conditions

Role: lead

NCT00652730Phase 1Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

Role: lead

NCT01994642Phase 3Terminated

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

Role: lead

NCT00652821Phase 1Completed

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

Role: lead

NCT01910155Phase 3Terminated

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

Role: lead

NCT00637403Phase 1Terminated

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

Role: lead

NCT00637728Phase 3Terminated

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Role: lead

NCT00637806Phase 3Terminated

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Role: lead

NCT01380457Phase 1Completed

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

Role: lead

NCT01380509Phase 1Completed

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

Role: lead

NCT01380522Phase 1Completed

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

Role: lead

NCT01380483Phase 1Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

Role: lead

NCT01380431Phase 1Completed

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

Role: lead

NCT01375244Phase 1Completed

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Role: lead

NCT00653549Phase 1Completed

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

Role: lead